Brentuximab vedotin after autologous stem cell transplant yields the strongest benefit in Hodgkin lymphoma patients with ≥2 risk factors: Results of a multivariate analysis Meeting Abstract
| Authors: | Moskowitz, C.; Sweetenham, J.; Chen, A.; Ayala, E.; Masszi, T.; Holowiecki, J.; Stiff, P.; Carella, A.; Viviani, S.; Bachanova, V.; Sureda, A.; Huebner, D.; Lee, S. Y.; Hunder, N.; Thomas, L.; Uttarwar, M.; Walewski, J. |
| Abstract Title: | Brentuximab vedotin after autologous stem cell transplant yields the strongest benefit in Hodgkin lymphoma patients with ≥2 risk factors: Results of a multivariate analysis |
| Meeting Title: | 10th International Symposium on Hodgkin Lymphoma (ISHL 10) |
| Keywords: | trial; consolidation; aethera |
| Journal Title: | Haematologica |
| Volume: | 101 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2016 Oct 22-25 |
| Meeting Location: | Cologne, Germany |
| ISSN: | 0390-6078 |
| Publisher: | Ferrata Storti Foundation |
| Date Published: | 2016-10-01 |
| Start Page: | 49 |
| Language: | English |
| ACCESSION: | WOS:000392549000115 |
| PROVIDER: | wos |
| PMCID: | PMC5080844 |
| Notes: | Meeting Abstract: P089 -- Source: Wos |
MSK Authors
-
407Moskowitz